Columna Capital

📢 Columna Capital announces the successful final close of Fund III at €290m! We are delighted to announce our third and largest fund capital raise since the launch of our maiden fund in 2016, underscoring strong investor confidence and demand despite a challenging fundraising environment. We’re especially pleased that 75% of existing investors increased their commitment in Fund III, and to have attracted a number of high-calibre new investors from across the world. It’s testament to the strong track record and commitment of the Columna Capital team, and we’re looking forward to continuing our partnership with exceptional entrepreneurs and businesses on their growth journeys to come. Get more details below, and click the link in the comments for more 👇 #ColumnaCapital #PrivateEquity #FundClose

A recent RECAP study reveals how our portfolio company PHYSIDIA’s S3 system is transforming home dialysis – making it more accessible, efficient, and less invasive. Here’s why it’s a game-changer: 1️⃣ Enhanced Patient Experience: Patients found the S3 system’s compact design and straightforward setup allowed many to regain a sense of normalcy — 25% of previously unemployed patients even returned to the workforce — a meaningful outcome in terms of quality of life and independence. 💼 2️⃣ Consistent Health Outcomes: With shorter, more frequent sessions, the S3 system provided stable health metrics—supporting effective blood pressure and toxin management without frequent hospital visits. 📊  3️⃣ Heart Health Gains: Intensive dialysis at home improved heart health markers, helping patients manage a common dialysis-related risk. 4️⃣ Bridge to Transplants: For 21% of patients, home dialysis on the S3 system was a step toward successful kidney transplants. 🌱 It’s an encouraging indicator that this technology can serve as a solid interim solution. For investors and healthcare leaders alike, the RECAP study underscores the potential of efficient, patient-centered home treatments like the S3 system to improve patient experiences and make a significant impact in the dialysis market. 🌟 👓 Follow PHYSIDIA to read more! #HealthcareInnovation #Dialysis #HomeDialysis #HomeHemodialysis #PatientExperience #PrivateEquity #PatientFreedom #QualityOfLife #PhysidiaS3 Source: FessiH et al. Physidia S³: RECAP Study. J Clin Med. 2023;12:1357.   

🌟 Save the date, Paris! We’re excited to announce that the Columna team will be attending the Healthcare Business International Conference in March 2025. It is the perfect opportunity to exchange insights, explore emerging trends, and connect with powerhouse healthcare professionals driving the industry's future. If you’ll be there too, let us know—we’d love to grab a coffee and chat! 📩 #HBI2025 #HealthcareBusiness #InnovationInHealthcare #Networking #HBIConferenceParis #HealthTech

We extend our sincere condolences to everyone affected by #DANA across Valencia, Castile-La Mancha, and Andalusia. Our thoughts are especially with families grieving loved ones and we deeply appreciate the dedication of emergency responders and medical professionals who continue to work tirelessly to support impacted communities. We are grateful to confirm the safety of all Zumex Group and Clínicas MiVet team members. While we anticipate some operational disruptions in the coming days, Columna is fully committed to standing by both portfolio companies and providing support as they navigate the challenges of recovery. ➡️ Resources: The Generalitat Valenciana has set up a dedicated support line at 900 365 112 for families of missing persons and the emergency number 112 is available for urgent assistance.   #FuerzaValencia

We’re thrilled to announce that our portfolio company, Zumex Group, has just launched their latest innovation—the Zitrux Compact! 🍊💧 This powerful new model is designed to help food retailers elevate their business and boost efficiency. With touchless operation, automatic self-sanitation and cleaning, plus a compact footprint, the #ZitruxCompact combines advanced technology with seamless functionality. Plus, it processes 40 fruits per minute, offering unmatched speed with built-in hygiene. Zumex continues to set the standard in food-tech innovation, and we’re proud to support them in this exciting new chapter. #Zumex #ZitruxCompact #JuicingRevolution #PEInnovation #NewLaunch Michael Tose Jaime Bachs Lobo Carlos Alonso Calleja Arnau Domènech Feliu Manu Santana Manfred Berbel

We’re thrilled to announce that our portfolio company, Zumex Group, has just launched their latest innovation—the Zitrux Compact! 🍊💧 This powerful new model is designed to help food retailers elevate their business and boost efficiency. With touchless operation, automatic self-sanitation and cleaning, plus a compact footprint, the #ZitruxCompact combines advanced technology with seamless functionality. Plus, it processes 40 fruits per minute, offering unmatched speed with built-in hygiene. Zumex continues to set the standard in food-tech innovation, and we’re proud to support them in this exciting new chapter. #Zumex #ZitruxCompact #JuicingRevolution #PEInnovation #NewLaunch Michael Tose Jaime Bachs Lobo Carlos Alonso Calleja Arnau Domènech Feliu Manu Santana Manfred Berbel

Il gruppo italiano di diagnostica integrata BIANALISI, controllato da Charme Capital Partners, Columna Capital e dall’imprenditore Giuliano Caslini, ha acquisito il 100% di Medilab, centro medico privato con sede principale ad Avezzano (AQ) e altre due sedi a L’Aquila e Cassino (FR). Nell’operazione, Bianalisi è stato assistito per gli aspetti legali dallo Studio Orrick Italia, per gli aspetti contabili e finanziari dai dottori Luca Zesi e Alberto Morandi di Deloitte e, per gli aspetti fiscali, dallo Studio ADVANT Nctm. Mediclinica è stata supportata dall’advisor ALTIOS International, guidato dal responsabile italiano Mirko Mottino e da Edoardo Musumeci, dallo Studio legale CastaldiPartners, e da Clas International con i professionisti Giuseppe Cerati, Luca Laurini e Luca Zuccotti. Leggi l'articolo completo >> https://lnkd.in/ddcNkRWi #Financecommunity #corporatefinance

🦷🤝 We’re proud to showcase the meaningful, on-going partnership between our portfolio company, Ardentis Cliniques Dentaires et d'Orthodontie, and Mercy Ships. Together with local communities, they are transforming dental care and education in Guinea. The inauguration of a new training centre at the University of Conakry (UGANC) is a key step in empowering Guinean dental students. This initiative reflects #Ardentis' dedication to sharing knowledge and resources to foster long-term growth, innovation, and to further strengthen the skillsets of future dentists. 👇 Learn more about this project and the partnership's impact in the original post below. #ProfessionalDevelopment #Upskilling #DentistPourTous #Partnership #MercyShips #UniversityofConakry

Last week, our co-founder and Managing Partner Rory Devlin took the stage at the Venture & Growth Equity Summit during IPEM Paris! 🎤 He joined the "Race for Scale & Renewed Growth" panel, exploring the evolving growth equity landscape alongside other industry leaders. They pulled out four key trends shaping the future: 🔑 Market Evolution: The past decade has seen a surge in competition within growth equity and venture markets. Entrepreneur expectations remain high, and investors need to offer more than just capital—they must bring deep, specialized sector knowledge and sharp insights into versatile business models to drive success. 💡 Investment Strategies: In today’s environment, the panellists agreed: it's all about backing proven, sustainable business models over speculative, hyper-growth bets. The key to long-term success? Focused value creation plans and buy-and-build strategies that expand beyond aggregation by realising synergies. 🤝 Origination in a Crowded Market: With an influx of GPs entering the space, it’s crucial to stand out by building trust, maintaining regular interactions with management, and consistently demonstrating clear value as a sponsor. A solid reputation and personalized support for entrepreneurs can make all the difference. 🔄 Continuation Vehicles (CVs): The panel also highlighted the growing importance of CVs for fostering ongoing partnerships and unlocking long-term growth for businesses. When coupled with transparency and alignment with LP interests, CVs offer flexible liquidity options and maximize asset potential well beyond traditional fund timelines. At Columna, we’re fully aligned with these insights. Our team's honed sector expertise across healthcare, animal health, insurance services, and agri-food allows us to drive sustainable growth for our portfolio companies. Our origination approach is all about building trusted partnerships and crafting value creation plans that are highly effective, collaborative, and allow us to hit the ground running. And as early adopters of CVs, we continue to use this tool in a transparent and properly de-risked manner to benefit our portfolio companies and LPs alike—delivering partnership continuity, reducing business disruption, and allowing access to new market opportunities while offering flexible liquidity and growth options. We’re excited about the opportunities ahead in this dynamic market! 🌱 👓 What trends are you watching closely right now? Let us know! Finally, a big thank you to IPEM for hosting another fantastic event and to our incredible fellow panellists for their insights: Pierre Barel (Federated Hermes Limited)  Keith Davidson (Scottish Equity Partners (SEP))  Xavier Lazarus (Elaia)  Alessandro Scortecci (CDP Venture Capital SGR)

Big news! 👏 We are delighted to welcome two outstanding new interns to Columna Capital: Arnau Domènech Feliu and Filippo Vidoni. Both bring impressive international experience, a passion for private equity, and a strong commitment to learning and growth. About Arnau: 🌍 Originally from Barcelona, Arnau is fluent in English, French, Spanish, and Catalan. 💼 He is motivated by the dynamic nature of PE, where strategic thinking and financial expertise come together to drive meaningful change in businesses. His interest lies in engaging with diverse industries, analysing their potential, and collaborating with management teams to implement sustainable growth strategies. 📚 Holds a Master’s in International Finance from HEC Paris and previously worked at AVANÇSA. About Filippo: 🌍 Filippo hails from Italy and speaks Italian, English, and French fluently, with basic knowledge of German. 💼 Filippo's entrepreneurial spirit drew him to PE. He enjoys solving complex challenges that require both a detailed focus and a broad, strategic view. At Columna, he is eager to further develop these skills and learn how to help build successful businesses. 📚 Has gained valuable experience working in start-ups and at I Squared Capital in London. We are excited to see the impact that both interns will make during their time at Columna, and we look forward to supporting them as they continue to grow in their careers. 📢To our network, please kindly join us in welcoming Arnau and Filippo to the team! #Welcome #PrivateEquityInternship #TeamGrowth #ProfessionalDevelopment